Acute basophilic leukaemia and translocation t(X;6)(p11;q23)

N Dastugue1, E Duchayne, E Kuhlein

  • 1Laboratoire d'Hématologie, CHU, Toulouse, France.

Insights

Two infants with acute basophilic leukemia, a rare leukemia subtype, were found to have a specific chromosomal abnormality, t(X;6)(p11;q23). This finding suggests a potential link between this genetic change and the disease, especially in infants.

Area of Science:

  • Hematology
  • Genetics
  • Pediatric Oncology

Background:

  • Acute basophilic leukemia (ABL) is a rare and aggressive subtype of acute leukemia.
  • The genetic underpinnings and distinct clinical presentations of ABL remain incompletely understood.
  • Infantile leukemia presents unique diagnostic and therapeutic challenges.

Observation:

  • Two infants presented with acute basophilic leukemia.
  • Both patients exhibited a t(X;6)(p11;q23) chromosomal translocation as the sole genetic abnormality.
  • Morphological analysis confirmed basophilic lineage via light and electron microscopy.

Findings:

  • The identified chromosomal abnormality, t(X;6)(p11;q23), appears to be non-randomly associated with ABL in infants.
  • Patients displayed a consistent clinical syndrome suggestive of hyperhistaminemia, including urticarial rashes and gastrointestinal issues.
  • Immunophenotypic analysis showed variability, with one patient expressing CD24, CD13, and CD33, and the other expressing CD117.

Implications:

  • This study identifies a potential new entity of infantile acute basophilic leukemia characterized by t(X;6)(p11;q23).
  • The distinct clinical presentation may aid in earlier diagnosis of this rare leukemia.
  • Further research into the pathobiology of ABL and its association with t(X;6)(p11;q23) is warranted.